GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Consensus Rating of “Moderate Buy” from Brokerages

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been assigned a consensus recommendation of “Moderate Buy” from the fifteen ratings firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $94.36.

Several research analysts have commented on GEHC shares. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price target for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Finally, BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Wednesday, September 18th.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Institutional Trading of GE HealthCare Technologies

Several large investors have recently modified their holdings of GEHC. Pathway Financial Advisers LLC purchased a new position in GE HealthCare Technologies during the 1st quarter valued at $25,000. LGT Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 251 shares during the period. Fred Alger Management LLC bought a new position in GE HealthCare Technologies in the second quarter worth about $26,000. Capital Performance Advisors LLP purchased a new stake in GE HealthCare Technologies in the third quarter worth about $26,000. Finally, Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies during the 3rd quarter valued at approximately $26,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Down 0.9 %

GE HealthCare Technologies stock opened at $84.18 on Thursday. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $38.46 billion, a P/E ratio of 23.13, a P/E/G ratio of 3.05 and a beta of 1.24. The firm has a 50 day moving average price of $88.85 and a 200-day moving average price of $83.48. GE HealthCare Technologies has a twelve month low of $66.39 and a twelve month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. During the same quarter in the previous year, the firm earned $0.99 EPS. The company’s quarterly revenue was up .9% compared to the same quarter last year. As a group, equities analysts predict that GE HealthCare Technologies will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.30%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.